More on Medtronic FQ1: Net profit +12%


Medtronic (MDT) revenue +2% to $4.1B, or +3% at constant currency rates (CCR).

Net profit +12% to $953M.

International revenue +9% at CCR to $1.89B, +6% as reported, and accounts for 46% of total; emerging markets revenue +15% to $504M, or 12% of total.

Reiterates FY 2014 outlook: EPS of +6-8% to $3.80-3.85 vs consensus of 3.84; and CCR revenue growth of 3-4%. (Previous) (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs